Back to top

BioMarin price target raised to $80 from $75 at Wells Fargo

Wells Fargo raised the firm’s price target on BioMarin (BMRN) to $80 from $75 and keeps an Overweight rating on the shares. The firm says the compa...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioMarin Pharmaceutical Inc. (BMRN)